Literature DB >> 7983657

Familial hypokalemia/hypomagnesemia and chondrocalcinosis.

T J Smilde1, J F Haverman, P Schipper, A R Hermus, F J van Liebergen, J L Jansen, P W Kloppenborg, M I Koolen.   

Abstract

OBJECTIVE: Familial occurrence of Bartter's syndrome is well known, but the simultaneous occurrence of hypokalemia/hypomagnesemia and chondrocalcinosis in one family has not been described. We present the clinical, laboratory and radiological findings of a family, in which 7 members were affected by disease.
METHODS: A total of 43 members of the family could be interviewed concerning their general health, past diseases and joint complaints. Serum potassium and magnesium were determined in all and radiographic studies were performed in those who had hypokalemia and hypomagnesemia or those with merely articular complaints. Urinary excretion of potassium, magnesium and calcium were determined in the affected persons.
RESULTS: Seven patients were found with hypokalemia and hypomagnesemia. Urinary potassium and magnesium excretion was inappropriately high when compared to the serum levels of these electrolytes. All patients had hypocalciuria and extensive chondrocalcinosis, mainly in the knees, elbows and shoulders. In one patient, most probably as a result of magnesium supplementation, a striking reduction of chondrocalcinosis was observed during a followup of 10 years.
CONCLUSION: A family with familial hypokalemia/hypomagnesemia and chondrocalcinosis is described. The reduction of chondrocalcinosis, after years of magnesium supplementation in one patient, suggests that hypomagnesemia is an important factor in the pathogenesis of chondrocalcinosis in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983657

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

Review 1.  Clinical trials review: crystal deposition diseases.

Authors:  R A Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 2.  The pathophysiological and molecular basis of Bartter's and Gitelman's syndromes.

Authors:  S Bhandari
Journal:  Postgrad Med J       Date:  1999-07       Impact factor: 2.401

Review 3.  Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.

Authors:  Akanksha Joshi; Chokkalingam Siva
Journal:  Eur J Rheumatol       Date:  2017-08-29

Review 4.  The long-term complications of the inherited tubulopathies: an adult perspective.

Authors:  Maryam Khosravi; Stephen B Walsh
Journal:  Pediatr Nephrol       Date:  2014-02-25       Impact factor: 3.714

5.  Treatment and management of pseudogout: insights for the clinician.

Authors:  Paul Macmullan; Geraldine McCarthy
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

Review 6.  Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.

Authors:  Salih Pay; Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 7.  Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.

Authors:  Hannsjörg W Seyberth; Karl P Schlingmann
Journal:  Pediatr Nephrol       Date:  2011-04-19       Impact factor: 3.714

Review 8.  Calcium pyrophosphate crystal deposition disease: diagnosis and treatment.

Authors:  José Luis Rosales-Alexander; Jerónimo Balsalobre Aznar; César Magro-Checa
Journal:  Open Access Rheumatol       Date:  2014-05-08

9.  Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis.

Authors:  Chao Zeng; Jie Wei; Robert Terkeltaub; Tuo Yang; Hyon K Choi; Yi-Lun Wang; Dong-Xing Xie; David J Hunter; Yuqing Zhang; Hui Li; Yang Cui; Liang-Jun Li; Guang-Hua Lei
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.